BRPI1012077A2 - combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica - Google Patents
combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêuticaInfo
- Publication number
- BRPI1012077A2 BRPI1012077A2 BRPI1012077A BRPI1012077A BRPI1012077A2 BR PI1012077 A2 BRPI1012077 A2 BR PI1012077A2 BR PI1012077 A BRPI1012077 A BR PI1012077A BR PI1012077 A BRPI1012077 A BR PI1012077A BR PI1012077 A2 BRPI1012077 A2 BR PI1012077A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- source
- combination
- fatty acid
- leucine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 title 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NLPCT/NL2009/050297 | 2009-05-27 | ||
| PCT/NL2009/050297 WO2010137944A1 (en) | 2009-05-27 | 2009-05-27 | Treatment of hypercalcaemia |
| PCT/NL2010/050319 WO2010137979A2 (en) | 2009-05-27 | 2010-05-27 | Hypercalcaemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1012077A2 true BRPI1012077A2 (pt) | 2018-03-20 |
| BRPI1012077B1 BRPI1012077B1 (pt) | 2021-05-18 |
| BRPI1012077B8 BRPI1012077B8 (pt) | 2022-09-20 |
Family
ID=41397536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1012077A BRPI1012077B8 (pt) | 2009-05-27 | 2010-05-27 | composição nutricional compreendendo uma combinação de uma fonte de leucina e uma fonte de ácido graxo poli-insaturado o-3, carboidratos digeríveis e fibra dietética solúvel |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20120122785A1 (pt) |
| EP (2) | EP2987485B1 (pt) |
| CN (2) | CN104257646A (pt) |
| BR (1) | BRPI1012077B8 (pt) |
| DK (1) | DK2435039T4 (pt) |
| ES (1) | ES2555860T5 (pt) |
| HU (1) | HUE028295T2 (pt) |
| MX (1) | MX2011012573A (pt) |
| PL (1) | PL2435039T5 (pt) |
| PT (1) | PT2435039E (pt) |
| RU (1) | RU2555359C2 (pt) |
| WO (2) | WO2010137944A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| WO2012141575A1 (en) | 2011-04-14 | 2012-10-18 | N.V.Nutricia | Combination of epa, dpa and/or dha with a chemotherapeutic agent |
| WO2012143405A1 (en) * | 2011-04-18 | 2012-10-26 | Nestec S.A. | Nutritional compositions having alpha-hica and alpha-ketoglutarate |
| WO2015002527A1 (en) | 2013-07-05 | 2015-01-08 | N.V. Nutricia | Amino acid composition for use in the treatment of a pdd |
| US9616292B2 (en) * | 2015-01-09 | 2017-04-11 | Nolan Orfield | Exercise tracker |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05178758A (ja) * | 1991-03-22 | 1993-07-20 | Suntory Ltd | トリペプチドを有効成分とする骨疾患の予防および治療剤 |
| EP0504938A3 (en) * | 1991-03-22 | 1993-04-14 | Suntory Limited | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
| JPH05140063A (ja) * | 1991-11-19 | 1993-06-08 | Suntory Ltd | ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤 |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| US20070037777A1 (en) * | 2005-08-12 | 2007-02-15 | Immunopath Profile, Inc. | Lipid-containing compositions and methods of using them |
| GB0003310D0 (en) | 2000-02-15 | 2000-04-05 | Univ Sheffield | Bone formation |
| NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| US20040171692A1 (en) * | 2003-02-28 | 2004-09-02 | Scutt Andrew | Modulation of bone formation |
| US20060159746A1 (en) | 2003-03-18 | 2006-07-20 | Troup John P | Compositions comprising fatty acids and amino acids |
| ATE433674T1 (de) * | 2003-06-23 | 2009-07-15 | Nestec Sa | Säuglingsnährpräparat oder folgemilch |
| JP4702678B2 (ja) * | 2004-06-07 | 2011-06-15 | 環境創研株式会社 | 競走馬用飼料添加材 |
| BRPI0513447A (pt) † | 2004-07-28 | 2008-06-10 | Abbott Lab | composições nutritivas e métodos para o tratamento ou prevenção de osteoporose |
| ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| GB0624879D0 (en) * | 2006-12-14 | 2007-01-24 | Shs Int Ltd | Treatment of pervasive development disorders |
| US20080171791A1 (en) * | 2007-01-11 | 2008-07-17 | Mdr Fitness Corp. | Compositions and Method for Losing Weight |
| US20080200425A1 (en) * | 2007-02-16 | 2008-08-21 | Kurtz Seymour J | Methods and compositions for regulating bone mineral density |
| WO2008147228A1 (en) * | 2007-05-31 | 2008-12-04 | Fonterra Corporate Research And Development Limited | Treatment or prevention of bone conditions |
| US7893067B2 (en) * | 2007-06-27 | 2011-02-22 | Medivir Ab | Cysteine protease inhibitors |
| EP2025248A1 (en) * | 2007-07-31 | 2009-02-18 | Fresenius Kabi Deutschland GmbH | Cachexia prevention supplement |
| WO2010002242A1 (en) * | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
| CN101314031A (zh) * | 2008-07-14 | 2008-12-03 | 王冰 | 一种改善骨营养的制剂 |
-
2009
- 2009-05-27 WO PCT/NL2009/050297 patent/WO2010137944A1/en active Application Filing
-
2010
- 2010-05-27 DK DK10726616.5T patent/DK2435039T4/da active
- 2010-05-27 WO PCT/NL2010/050319 patent/WO2010137979A2/en active Application Filing
- 2010-05-27 EP EP15184059.2A patent/EP2987485B1/en active Active
- 2010-05-27 CN CN201410488463.7A patent/CN104257646A/zh active Pending
- 2010-05-27 RU RU2011152873/15A patent/RU2555359C2/ru active
- 2010-05-27 PT PT107266165T patent/PT2435039E/pt unknown
- 2010-05-27 PL PL10726616T patent/PL2435039T5/pl unknown
- 2010-05-27 HU HUE10726616A patent/HUE028295T2/en unknown
- 2010-05-27 MX MX2011012573A patent/MX2011012573A/es not_active Application Discontinuation
- 2010-05-27 BR BRPI1012077A patent/BRPI1012077B8/pt active IP Right Grant
- 2010-05-27 US US13/322,730 patent/US20120122785A1/en not_active Abandoned
- 2010-05-27 CN CN201080033424.8A patent/CN102458390B/zh active Active
- 2010-05-27 EP EP10726616.5A patent/EP2435039B2/en active Active
- 2010-05-27 ES ES10726616T patent/ES2555860T5/es active Active
-
2014
- 2014-07-25 US US14/341,106 patent/US9867796B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE028295T2 (en) | 2016-12-28 |
| RU2555359C2 (ru) | 2015-07-10 |
| BRPI1012077B8 (pt) | 2022-09-20 |
| DK2435039T3 (en) | 2015-12-21 |
| EP2435039A2 (en) | 2012-04-04 |
| ES2555860T3 (es) | 2016-01-11 |
| EP2987485A1 (en) | 2016-02-24 |
| WO2010137944A1 (en) | 2010-12-02 |
| WO2010137979A2 (en) | 2010-12-02 |
| DK2435039T4 (da) | 2019-05-06 |
| WO2010137979A3 (en) | 2011-04-14 |
| CN104257646A (zh) | 2015-01-07 |
| EP2435039B2 (en) | 2019-02-27 |
| EP2987485B1 (en) | 2020-02-26 |
| CN102458390B (zh) | 2014-10-29 |
| PT2435039E (pt) | 2016-01-08 |
| EP2435039B1 (en) | 2015-09-09 |
| US9867796B2 (en) | 2018-01-16 |
| PL2435039T5 (pl) | 2019-09-30 |
| ES2555860T5 (es) | 2019-07-12 |
| RU2011152873A (ru) | 2013-07-10 |
| US20120122785A1 (en) | 2012-05-17 |
| MX2011012573A (es) | 2011-12-14 |
| BRPI1012077B1 (pt) | 2021-05-18 |
| WO2010137979A8 (en) | 2011-11-17 |
| PL2435039T3 (pl) | 2016-02-29 |
| US20150018277A1 (en) | 2015-01-15 |
| CN102458390A (zh) | 2012-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0915149A2 (pt) | Composição nutricional, e usos de uma composição, e de um produto derivado de leite | |
| BR112012018842A8 (pt) | composição nutritiva enteral líquida e uso de uma composição nutritiva líquida | |
| BR112012000421A2 (pt) | composições e métodos para intensificar a produção de um produto biológico. | |
| DK2252167T3 (da) | Højprotein flydende enteral næringssammensætning | |
| HK1164163A1 (zh) | 半固態組合物和藥劑學產品 | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BR112013016187A2 (pt) | Produtos nutricionais compreendendo beta- hidróxi-beta metilbutirato de cálcio e ácido linoléico conjungado. | |
| DK2508083T3 (da) | Biologisk aktivt kosttilskud til profylakse af osteoporose sygdomme | |
| EP2488180A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT / PROPHYLAXIS OF NON ALCOHOLIC HEPATIC STEATOSIS | |
| FR2948568B1 (fr) | Formulation pharmaceutique | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| BR112012005783A2 (pt) | composições nutricionais incluindo vitamina k2 exógena | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| BRPI1014529A2 (pt) | Composições de monoglicerídeo de ácido graxo | |
| EP2616059A4 (en) | PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS OF ABSCISIC ACID | |
| EP2616053A4 (en) | PHARMACEUTICAL COMPOSITIONS FROM CURCUMIN | |
| BRPI1012077A2 (pt) | combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica | |
| PL2557943T3 (pl) | Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki | |
| BR112012015082A2 (pt) | compressor de uma hélice | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| HK1177695A1 (en) | Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d- | |
| BR112012003149A2 (pt) | composição farmacêutica | |
| PL2538955T3 (pl) | Formulacja farmaceutyczna lub nutraceutyczna | |
| BRPI1006076A2 (pt) | composicoes farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/05/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/05/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B16B | Notification of grant cancelled [chapter 16.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: RETIFICACAO REF. RPI 2628 DE 18/05/2021. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 18/05/2021, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS. |